Excitatory amino acids as a final common pathway for neurologic disorders.
Lipton
S A
SA
Harvard-Longwood Neurology Program, Boston, MA 02115.
Rosenberg
P A
PA
D001692:Biological Transport; D001927:Brain Diseases / Q000188:drug therapy / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D005971:Glutamates / Q000378:metabolism; D018698:Glutamic Acid; D006801:Humans; D016202:N-Methylaspartate / Q000378:metabolism; D009474:Neurons / Q000201:enzymology / Q000378:metabolism; D017470:Receptors, Glutamate / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology
D005971:Glutamates; D017470:Receptors, Glutamate; D018698:Glutamic Acid; D016202:N-Methylaspartate; D002118:Calcium